Edge Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-600
| Closed | -$226K | – | 184 |
|
|
2021
Q4 | $226K | Hold |
600
| – | – | 0.04% | 87 |
|
|
2021
Q3 | $248K | Hold |
600
| – | – | 0.05% | 87 |
|
|
2021
Q2 | $222K | Hold |
600
| – | – | 0.05% | 88 |
|
|
2021
Q1 | $174K | Hold |
600
| – | – | 0.04% | 97 |
|
|
2020
Q4 | $150K | Hold |
600
| – | – | 0.03% | 102 |
|
|
2020
Q3 | $136K | Hold |
600
| – | – | 0.03% | 126 |
|
|
2020
Q2 | $105K | Hold |
600
| – | – | 0.02% | 194 |
|
|
2020
Q1 | $76K | Hold |
600
| – | – | 0.02% | 195 |
|
|
2019
Q4 | $92K | Hold |
600
| – | – | 0.02% | 198 |
|
|
2019
Q3 | $79K | Hold |
600
| – | – | 0.02% | 210 |
|
|
2019
Q2 | $86K | Hold |
600
| – | – | 0.02% | 206 |
|
|
2019
Q1 | $87K | Hold |
600
| – | – | 0.02% | 195 |
|
|
2018
Q4 | $68K | Hold |
600
| – | – | 0.02% | 217 |
|
|
2018
Q3 | $81K | Hold |
600
| – | – | 0.02% | 214 |
|
|
2018
Q2 | $67K | Hold |
600
| – | – | 0.02% | 218 |
|
|
2018
Q1 | $64K | Hold |
600
| – | – | 0.02% | 204 |
|
|
2017
Q4 | $66K | Hold |
600
| – | – | 0.02% | 196 |
|
|
2017
Q3 | $65K | Hold |
600
| – | – | 0.02% | 197 |
|
|
2017
Q2 | $61K | Hold |
600
| – | – | 0.02% | 205 |
|
|
2017
Q1 | $54K | Hold |
600
| – | – | 0.02% | 204 |
|
|
2016
Q4 | $46K | Hold |
600
| – | – | 0.02% | 197 |
|
|
2016
Q3 | $50K | Hold |
600
| – | – | 0.02% | 181 |
|
|
2016
Q2 | $49K | Hold |
600
| – | – | 0.02% | 174 |
|
|
2016
Q1 | $46K | Hold |
600
| – | – | 0.02% | 180 |
|
|
2015
Q4 | $49K | Hold |
600
| – | – | 0.02% | 189 |
|
|
2015
Q3 | $38K | Hold |
600
| – | – | 0.01% | 195 |
|
|
2015
Q2 | $42K | Hold |
600
| – | – | 0.01% | 197 |
|
|
2015
Q1 | $48K | Hold |
600
| – | – | 0.02% | 195 |
|
|
2014
Q4 | $39K | Hold |
600
| – | – | 0.01% | 214 |
|
|
2014
Q3 | $36K | Hold |
600
| – | – | 0.01% | 216 |
|
|
2014
Q2 | $32K | Hold |
600
| – | – | 0.01% | 210 |
|
|
2014
Q1 | $36K | Hold |
600
| – | – | 0.02% | 195 |
|
|
2013
Q4 | $32K | Hold |
600
| – | – | 0.01% | 188 |
|
|
2013
Q3 | $28K | Hold |
600
| – | – | 0.02% | 174 |
|
|
2013
Q2 | $25K | Buy |
+600
| New | +$25.7K | 0.02% | 170 |
|
Other funds holding CRL
Edge Wealth Management's CRL Position: Q1 2022 in Review
Edge Wealth Management sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 600 shares — an estimated $226K sold.
Edge Wealth Management first reported a position in CRL in Q2 2013 and held it in 35 quarters. The position peaked at $248K in Q3 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.
- Edge Wealth Management reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
- Edge Wealth Management sold 600 Charles River Laboratories shares in Q1 2022, an estimated $226K.
- Edge Wealth Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 35 quarters.
- Edge Wealth Management's Charles River Laboratories position peaked at $248K in Q3 2021.
- 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.
Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.